Charles River Laboratories International, Inc. (CRL)

CRL Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 30, 2023	Dec 31, 2022	Dec 25, 2021	Dec 26, 2020	Dec 28, 2019
Market Capitalization	11,242	12,127	11,086	18,631	12,521	7,420
Market Cap Growth	35.21%	9.38%	-40.50%	48.81%	68.74%	38.09%
Enterprise Value	13,993	14,916	13,950	21,307	14,428	9,187
PE Ratio	26.31	25.55	22.80	47.65	34.37	29.44
PS Ratio	2.73	2.94	2.79	5.26	4.28	2.83
PB Ratio	3.09	3.37	3.73	7.35	5.92	4.54
P/FCF Ratio	27.18	33.19	37.59	35.02	32.95	21.80
P/OCF Ratio	15.96	17.73	17.89	24.49	22.91	15.43
EV/Sales Ratio	3.40	3.61	3.51	6.02	4.93	3.50
EV/EBITDA Ratio	13.96	14.53	14.24	26.23	18.80	16.37
EV/EBIT Ratio	20.57	20.94	20.64	38.97	27.09	25.31
EV/FCF Ratio	33.83	40.82	47.30	40.05	37.97	26.99
Debt / Equity Ratio	0.85	0.85	1.04	1.15	1.01	1.23
Debt / EBITDA Ratio	3.07	2.99	3.16	3.59	2.78	3.57
Debt / FCF Ratio	7.44	8.39	10.50	5.48	5.62	5.89
Quick Ratio	1.17	1.00	0.90	0.86	1.01	1.06
Current Ratio	1.75	1.53	1.32	1.23	1.43	1.44
Asset Turnover	0.52	0.53	0.54	0.53	0.55	0.59
Interest Coverage	4.95	5.21	11.40	7.40	6.16	5.96
Return on Equity (ROE)	12.70%	14.30%	17.90%	16.50%	19.60%	16.70%
Return on Assets (ROA)	5.50%	6.10%	6.60%	5.90%	6.90%	5.70%
Return on Capital (ROIC)	7.01%	7.64%	8.45%	8.95%	8.31%	8.05%
Earnings Yield	3.90%	3.91%	4.39%	2.10%	2.91%	3.40%
FCF Yield	3.68%	3.01%	2.66%	2.86%	3.04%	4.59%
Buyback Yield / Dilution	-0.81%	-0.29%	0.24%	-1.61%	-1.85%	-1.38%
Total Shareholder Return	-0.81%	-0.29%	0.24%	-1.61%	-1.85%	-1.38%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).